News & Events

British women will soon be offered IVF with embryos selected by artificial intelligence. About a dozen clinics are preparing to…

An interview in Fernch with Daniella Gilboa, the co-founder and CEO of AIVF.

“Without the use of AI, traditional clinicians have been tasked with guessing which embryo will be most viable.”

AIVF, a reproductive technology company based in Tel Aviv, Israel, aims to improve the odds. Its AI-powered embryo evaluation software, called EMA,…

The World Economic Forum announces selection of the 100 most promising Technology Pioneers, companies that are tackling such issues as…

“AIVF is focused on commercial growth in Europe and intensive user research for future innovations.”

For couples having children through IVF, fertility doctors guiding the process are the ones who receive the credit for success.…

“While AI is spurring success, barriers to treatment remain, says Daniella Gilboa, CEO of AIVF.”

AIVF, and Genea Biomedx, announced the launch of their integrated system.”

“Integrating AI platforms will allow IVF clinics to scale to meet the rising demand for Assistive Reproductive Technology.”

“AIVF will use the funding to fuel adoption of the company’s AI platform, EMA™ in the United States and Europe.”

“The company has already received the European CE Mark for its AI-based platform.”

“AIVF has developed the Embryology Management Assistant, or EMA™, a software platform for fertility clinics to add data-driven AI capabilities”.

“The AIVF solution allows for a significant increase in the number of patients receiving successful treatment.”

“At AiVF, we replace subjective human analysis with data-driven decision making, while bringing automation and full transparency to the IVF…